Center Star Asset Management, LLC Bristol Myers Squibb CO Put Options Transaction History

Center Star Asset Management, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $5.58 Million - $6.14 Million	-76,800 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $4.72 Million - $5.66 Million	76,800 New	76,800 $4.85 Million
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $2.89 Million - $3.14 Million	-46,600 Closed	0 $0
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $718,014 - $807,553	12,100 Added 35.07%	46,600 $2.71 Million
Q4 2020 Jan 27, 2021	BUY	$57.74 - $65.43 $1.43 Million - $1.62 Million	24,700 Added 252.04%	34,500 $1.98 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $1.57 Million - $2.28 Million	-33,800 Reduced 77.52%	9,800 $115,000
Q3 2019 Oct 24, 2019	BUY	$42.77 - $50.71 $1.86 Million - $2.21 Million	43,600 New	43,600 $45,000
Q1 2019 Apr 29, 2019	SELL	$45.12 - $53.8 $3.22 Million - $3.84 Million	-71,400 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$48.76 - $63.23 $3.42 Million - $4.44 Million	-70,200 Reduced 49.58%	71,400 $546,000
Q3 2018 Oct 15, 2018	BUY	$55.19 - $62.25 $7.81 Million - $8.81 Million	141,600 New	141,600 $169,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.